Wenchang Yu

机构：Fujian Medical University, Central South University, Sun Yat-sen University, Chizhou University, Sun Yat-sen Memorial Hospital, Hainan General Hospital, Fujian Provincial Cancer Hospital, Putian University

发表论文 28 篇 · 总被引 1393 次 · h-index 10

代表论文

• Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial (2023 · The Lancet · 被引 1103)
• Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations (2023 · Hepatology International · 被引 57)
• Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma (2018 · BMC Cancer · 被引 51)
• Comparison of high‐intensity interval training and moderate‐intensity continuous training on cardiopulmonary function, cardiac autonomic function and vascular function in adolescent boys with obesity: A randomized controlled trial (2024 · European Journal of Sport Science · 被引 18)
• Apatinib plus hepatic arterial infusion of oxaliplatin and raltitrexed for hepatocellular carcinoma with extrahepatic metastasis: phase II trial (2024 · Nature Communications · 被引 17)
• Comparison of Arterial Infusion Chemotherapy and Chemoembolization for Locally Advanced Hepatocellular Carcinoma: a Multicenter Retrospective Study (2022 · Journal of Gastrointestinal Surgery · 被引 13)